Financhill
Back

DBV Technologies SA Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
30

DBVT
DBV Technologies SA

Last Price:
0.49
Seasonality Move:
-2.38%
Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.63
Seasonality Move:
50.57%
Sell
30
DBV Technologies SA (DBVT) is a Sell

Is DBV Technologies SA a Buy, Sell or Hold?

  • The current DBV Technologies SA [DBVT] share price is $0.51. The Score for DBVT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • DBVT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DBVT Stock Price Chart

What is DBV Technologies SA's stock price today?

  • The DBV Technologies SA share price today is $0.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBVT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.

DBVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: 24500 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.8) Sell
Bollinger Bands (100): (0.68 - 0.9) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 38.6 Sell
Chaikin Money Flow: -1006052 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.67 - 0.83) Sell
Bollinger Bands (100): (0.81 - 1.21) Sell

DBVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Sell
20-day SMA: 0.7 Sell
50-day SMA: 0.7 Sell
200-day SMA: 1.09 Sell
8-day EMA: 0.57 Sell
20-day EMA: 0.65 Sell
50-day EMA: 0.72 Sell
200-day EMA: 1.13 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.69 Sell
20-day SMA: 0.74 Sell
50-day SMA: 0.86 Sell
200-day SMA: 1.12 Sell
8-day EMA: 0.68 Sell
20-day EMA: 0.74 Sell
50-day EMA: 0.84 Sell
200-day EMA: 1 Sell

DBV Technologies SA Earnings Growth & DBVT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.19 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

DBV Technologies SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):